Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Linxin Xu"'
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 5, Pp 608-613 (2024)
ABSTRACT Aims/Introduction Serum asprosin is expected to become a screening indicator in early‐stage diabetic heart disease. The relationship between serum asprosin and left ventricular diastolic dysfunction (LVDD) was studied in elderly patients w
Externí odkaz:
https://doaj.org/article/e28cf07472f24b52a055e8f23cac16ff
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Background To explore the association of serum asprosin levels with metabolic dysfunction-associated fatty liver disease (MAFLD) in older adults with type 2 diabetes mellitus (T2DM). Methods The cross-sectional study enrolled patients ≥ 65
Externí odkaz:
https://doaj.org/article/ecdbbf208bad4f53a0064d164b4ec6a4
Autor:
Junfang Cui, Zhengqian Wang, Jianhong Yin, Mina Li, Qianqian Wu, Ming Liu, Hong Su, Huijuan Ren, Minggang Xu, Jing Yang, Linxin Xu
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectivesThis study aimed to investigate the link between 25-hydroxy vitamin D and serum asprosin in individuals with type 2 diabetes within the community. The goal was to provide a foundation for clinical interventions.MethodsBetween November 2019
Externí odkaz:
https://doaj.org/article/5d64c18c08934565b25e6208075cfe89
Autor:
Wei Fu, Linxin Xu, Qiwen Yu, Jiajia Fang, Guohua Zhao, Yi Li, Chenying Pan, Hao Dong, Di Wang, Haiyan Ren, Yi Guo, Qingjun Liu, Jun Liu, Xing Chen
Publikováno v:
ACS Omega, Vol 7, Iss 5, Pp 4001-4010 (2022)
Externí odkaz:
https://doaj.org/article/38012e6b45f34405a1d975d7f70c45aa
Autor:
Xiaochen Yu, Ziyu Meng, Ting Fang, Xiaohuan Liu, Ying Cheng, Linxin Xu, Xiangyang Liu, Xiaoyu Li, Mei Xue, Ting Li, Bei Sun, Liming Chen
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
Increases in glucose production and decreases in hepatic glycogen storage induce glucose metabolic abnormalities in type 2 diabetes (T2DM). Empagliflozin, a sodium-dependent glucose transporter 2 (SGLT2) inhibitor, is an effective hypoglycemic drug;
Externí odkaz:
https://doaj.org/article/a5b57aded9144ea3a54e7ace3c2433b8
Autor:
Linxin Xu, Chaofei Xu, Xiangyang Liu, Xiaoyu Li, Ting Li, Xiaochen Yu, Mei Xue, Jing Yang, Constantine E. Kosmas, Dimitrios Moris, Fabian Sanchis-Gomar, Naofumi Yoshida, Nathan A. Berger, Wilbert S. Aronow, Bei Sun, Liming Chen
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Background: White adipose tissue (WAT) browning is a promising target for obesity prevention and treatment. Empagliflozin has emerged as an agent with weight-loss potential in clinical and in vivo studies, but the mechanisms underlying its effect are
Externí odkaz:
https://doaj.org/article/7096b062004346249eb2962328e1a7d8
Autor:
Chenguang Li, Jie Zhang, Mei Xue, Xiaoyu Li, Fei Han, Xiangyang Liu, Linxin Xu, Yunhong Lu, Ying Cheng, Ting Li, Xiaochen Yu, Bei Sun, Liming Chen
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-13 (2019)
Abstract Background Hyperglycaemia associated with myocardial oxidative stress and fibrosis is the main cause of diabetic cardiomyopathy. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor has recently been reported to improve glycaemi
Externí odkaz:
https://doaj.org/article/4ba6523e673b443a95b9427ec8314d14
Autor:
Ting Li, Ting Fang, Linxin Xu, Xiangyang Liu, Xiaoyu Li, Mei Xue, Xiaochen Yu, Bei Sun, Liming Chen
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: Metabolic associated fatty liver disease (MAFLD), characterized by hepatic lipid accumulation and fatty degeneration, is intertwined with obesity and type 2 diabetes mellitus (T2DM). Empagliflozin is a sodium-glucose cotransporter-2 inhib
Externí odkaz:
https://doaj.org/article/1939e010d8d4431e91178eeb06efca9c
Autor:
Qiwen Yu, Jing Chen, Wei Fu, Kanhar Ghulam Muhammad, Yi Li, Wenxin Liu, Linxin Xu, Hao Dong, Di Wang, Jun Liu, Yanli Lu, Xing Chen
Publikováno v:
Biosensors, Vol 12, Iss 4, p 223 (2022)
Lung cancer has been studied for decades because of its high morbidity and high mortality. Traditional methods involving bronchoscopy and needle biopsy are invasive and expensive, which makes patients suffer more risks and costs. Various noninvasive
Externí odkaz:
https://doaj.org/article/73d0beac90964bfa96fbace3488881b1
Autor:
Linxin Xu, Ting Li, Jianhong Yin, Gang Lin, Yali Xu, Yi Ren, Yan Wang, Jing Yang, Liming Chen
Publikováno v:
PeerJ, Vol 7, p e7563 (2019)
Background To investigate whether SUA is associated with NAFLD in men and women with T2DM. Methods This cross-sectional study enrolled patients with T2DM at Shanxi High-Tech Development Zone Central Hospital (June 2011 to September 2017). Patients we
Externí odkaz:
https://doaj.org/article/1420ce847e61419b82efb6d9d4831695